Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,069
  • Shares Outstanding, K 101,993
  • Annual Sales, $ 36,120 K
  • Annual Income, $ -232,490 K
  • EBIT $ -97 M
  • EBITDA $ -7 M
  • 60-Month Beta 2.37
  • Price/Sales 0.67
  • Price/Cash Flow N/A
  • Price/Book 0.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.12
  • Most Recent Earnings $-0.32 on 11/14/24
  • Next Earnings Date 11/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 531.91% ( +232.37%)
  • Historical Volatility 86.10%
  • IV Percentile 99%
  • IV Rank 94.19%
  • IV High 563.22% on 11/12/24
  • IV Low 24.63% on 09/19/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 140
  • Volume Avg (30-Day) 357
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 41,060
  • Open Int (30-Day) 41,459

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +104,162.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2000 +27.80%
on 11/21/24
0.3760 -32.02%
on 10/30/24
-0.0575 (-18.36%)
since 10/29/24
3-Month
0.2000 +27.80%
on 11/21/24
0.5086 -49.74%
on 09/27/24
-0.2276 (-47.10%)
since 08/29/24
52-Week
0.2000 +27.80%
on 11/21/24
2.2700 -88.74%
on 12/28/23
-1.3244 (-83.82%)
since 11/29/23

Most Recent Stories

More News
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript

BNGO earnings call for the period ending September 30, 2024.

BNGO : 0.2556 (+7.30%)
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

BNGO : 0.2556 (+7.30%)
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

BNGO : 0.2556 (+7.30%)
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.2556 (+7.30%)
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

BNGO : 0.2556 (+7.30%)
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.2556 (+7.30%)
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma

BNGO : 0.2556 (+7.30%)
Bionano Announces Preliminary 3Q 2024 Revenues and Cash

BNGO : 0.2556 (+7.30%)
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024

BNGO : 0.2556 (+7.30%)
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2024.

BNGO : 0.2556 (+7.30%)

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 0.2839
2nd Resistance Point 0.2719
1st Resistance Point 0.2638
Last Price 0.2556
1st Support Level 0.2437
2nd Support Level 0.2317
3rd Support Level 0.2236

See More

52-Week High 2.2700
Fibonacci 61.8% 1.4793
Fibonacci 50% 1.2350
Fibonacci 38.2% 0.9907
Last Price 0.2556
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar